Nanotechnology enables reduced doses through several mechanisms:
1. Enhanced Bioavailability: Nanoparticles can improve the solubility and stability of drugs, leading to better absorption and distribution within the body. 2. Targeted Delivery: Nanocarriers can be engineered to target specific cells or tissues, ensuring that the therapeutic agent accumulates at the disease site, thereby reducing systemic exposure and side effects. 3. Controlled Release: Nanoparticles can be designed for sustained and controlled release of drugs, maintaining therapeutic levels for extended periods and decreasing the frequency of administration.
